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ABSTRACT: The bone marrow niche represents a speci-
alized environment that regulates mesenchymal stem cell
quiescence and self-renewal, yet fosters stem cell migration
and diﬀerentiation upon demand. An in vitro model that
embodies these features would open up the ability to
perform detailed study of stem cell behavior. In this paper
we present a simple bone marrow-like niche model, which
comprises of nanomagnetically levitated stem cells cultured
as multicellular spheroids within a type I collagen gel. The
stem cells maintained are nestin positive and remain
quiescent until regenerative demand is placed upon them.
In response to coculture wounding, they migrate and
appropriately diﬀerentiate upon engraftment. This tissue
engineered regeneration-responsive bone marrow-like niche model will allow for greater understanding of stem cell
response to injury and also facilitate as a testing platform for drug candidates in a multiwell plate format.
KEYWORDS: mesenchymal stem cells, bone marrow niche, magnetic nanoparticles, tissue engineering, migration, scratch assay,
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The bone marrow is resident to multipotent mesen-chymal stem cells (MSCs), which are localized in aniche environment regulating MSC quiescence, self-
renewal, and diﬀerentiation.1,2 Aside from the beneﬁts of
multipotency, MSCs home to sites of cellular injury by
migrating from the niche to the injured tissue on regenerative
demand; these attributes make them key targets for potential
clinical use and make modeling the niche to allow deeper
understanding a major research drive.3,4 In this report, we
present an in vitro niche model that is not only simple and
quick to assemble but also mimics the MSC niche with the
capacity to support viable, nestin+, quiescent MSCs within a
low stiﬀness collagen I scaﬀold simulating bone marrow. The
use of superparamagnetic nanoparticles (SPION) to achieve
magnetic levitation allows us to generate multicellular MSC
spheroids within a few hours rather than days as required by
other established methods, e.g., hanging drop. However, and
critically, the use of SPION allows ease of cell tracking, and
thus we demonstrate that our nanoniches can respond to
regenerative demand through cell migration, engraftment, and
desired diﬀerentiation when we model neighboring tissue
damage (reticular, bony, and cartilaginous). We note that an
increasing number of in vivo studies have established that bone
marrow MSCs selectively home to sites of injury.5 However, a
reductionist, in vitro, model has remained elusive, and this has
prevented greater understanding of MSC response to injury.
Our model draws on recent advances in 2D and 3D culture
model design that validate the need for maintaining cell−cell
and cell−matrix interactions in order to regulate MSC
multipotency and self-renewal, thus mimicking the natural
bone marrow microenvironment.6−9 An avenue of particular
simplicity and, hence, promise is adopting multicellular
spheroids.10 MSCs cultured as 3D multicellular spheroids are
known to maintain cell−cell contacts and become quiescent.11
Using our SPION approach, we present an alternative
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methodology that speeds up niche formation and develops this
further to introduce a 3D extracellular matrix environment. The
bone marrow is a low-stiﬀness collagenous matrix, and it is
notable that MSCs cultured in low-stiﬀness biomaterials express
cell surface markers such as nestin.12−14 Nestin, normally
considered a neural marker, is now recognized as being key in
cell−cell interaction, motility, and signaling within the niche;
within the marrow, hematopoietic stem cell (HSC) home to
resident nestin+ MSCs. It is postulated that expression of such
proteins may be due to the tendency of adult stem cell niches
to be associated with adrenergic nerve ﬁbers linking niches to
circadian regulation.15 If MSCs do not express nestin in the
niche, then HSCs mobilize to the spleen.16
Figure 1. Monolayer and spheroid timeline culture of mNP labeled MSCs. (A) Images were taken at days 1 and 14 within media assessing;
vertical panel 1 cell viability (green = living cells, red = dead cells, 10× objective), panel 2 and 3 phenotype (red = STRO-1/nestin, blue =
nucleus, 20× objective) and panel 4 proliferation (red = proliferating, blue = nuclei). Scale bar = 50 μm. Note the decreasing MSC phenotype
with time in monolayer, with increasing cell division and growth, while MSC phenotype is maintained in spheroid culture, with cessation of
cell division. (B) Graph indicates quantitative analysis of STRO-1 and nestin in monolayer and spheroid culture at days 1, 3, 5, and 14 (n = 3
samples; 6 image from each). (Error bars denote standard deviation; * indicates statistical signiﬁcance where p < 0.05, ** indicates p < 0.01
and *** indicates p < 0.001 as calculated using one way ANOVA.) Note progressive loss of marker in monolayer with retention in spheroid
culture.
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RESULTS AND DISCUSSION
MSC Spheroids are Viable, Quiescent and Express
STRO-1 and Nestin. To produce our MSC spheroids, primary
human bone marrow MSCs were initially labeled with
ﬂuorescent magnetic nanoparticles (Supplementary Figures
1−4) in monolayer, with the particles being retained within the
cells post-trypsinization (Supplementary Figure 4). Once
labeled, the cells were retrypsinized and levitated in cell
media within a 24-well plate via an external magnet above the
plate; this coerces the cells together to form a multicellular
spheroid via “magnetic levitation”. The magnetic ﬁeld has been
previously characterized and is suﬃcient to permit spheroid
generation at the media/air liquid interface.17,18 Aside from the
original cell seeding density, spheroid generation via magnetic
levitation does not permit exact control over spheroid size and
shape, however spheroids form with a mean diameter of 259
μm (Supplementary Figure 5). After formation (∼3 h), the
external magnets were removed, and the spheroids were
subsequently transplanted into a soft type I collagen gel
(Supplementary Figure 6), with a modulus akin to bone
marrow (Supplementary Figure 7; 40 Pa Young’s Modulus).
The MSCs were viable, maintained high expression of the stem
cell markers STRO-1 and nestin, and were quiescent within
their magnetic spheroids for up to day 14, as compared to
standard cultures in monolayer where MSCs proliferated and
stem cell markers were lost by day 3 of culture (Figure 1).
Furthermore, the MSCs cultured in spheroids remained
multipotent and were capable of diﬀerentiation into both
osteoblasts, adipocytes, with expression of chondrogenic
transcription markers after spheroid dissociation and culture
in monolayer (Supplementary Figures 8, 9) and secreted
increasing levels of CXCL12 with time in culture (Supple-
mentary Figure 10).
MSCs Transmigrate from the Spheroid Niche Toward
Cocultured Wound Sites.With a view to assessing the MSCs
potential to home and engraft from the niche model to sites of
Figure 2. Control (upper) and activated (lower) ﬁbroblast and osteoblasts monolayer wound healing assay, with spheroid coculture above.
MSC spheroids cultured in a type I collagen gel directly over both an intact ﬁbroblast and primary osteoblast monolayer (upper panel) and a
scratched (activated) monolayer (lower panel); dashed line indicates wound edge. (A) Light microscopy images of spheroids; (B)
immunoﬂuorescent images of spheroids and monolayer cells (red = actin, green = mNPs, blue = nucleus). 10× objective, scale bar = 50 μm.
Note the lack of MSC migration in control cultures, with MSC migration from the spheroid toward the wound in activated cultures.
Arrowheads denote examples of migrations cells (labeled green with NPs in ﬂuorescent image).
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injury, the MSC spheroids were cocultured with a simple
wound healing model. Brieﬂy, this entailed either human
ﬁbroblasts or osteoblasts being cultured in multiwell plates in
monolayer and scratched with a pipet tip to create a wound
(Supplementary Figure 11), and the spheroids contained within
collagen gels being immediately overlaid. MSC response was
initially gauged over 3 days of culture. When the spheroids were
cocultured over intact ﬁbroblast and osteoblast monolayers (i.e.,
unscratched controls), the MSCs remained within the
spheroids (Figure 2). However, when cocultured over wounded
ﬁbroblast and osteoblast monolayers (i.e., activated cultures in
need of regeneration), the MSCs migrated out of the spheroids
toward the wound, appearing to incorporate and engraft into
the underlying monolayer (Figure 2). This MSC migration and
incorporation into the ﬁbroblast and osteoblast monolayers
closely reﬂect the in vivo situation of MSC homing and
engraftment in response to injured tissues.
Following Transmigration, MSCs Diﬀerentiate Appro-
priately to Assist Tissue Regeneration. We subsequently
determined whether the MSCs were changing phenotype
during transmigration toward the wound. This was assessed by
repeating the MSC spheroid coculture with the ﬁbroblast,
osteoblast, and additionally chondrocyte wound models.
Osteoblast diﬀerentiation analysis of early and late osteoblast
Figure 3. MSC osteoblastic diﬀerentiation during wound healing. (A) MSC migration and osteoblast diﬀerentiation assessed at days 3 and 14
of culture, in control and activated wound models. (i) Light microscopy image of spheroids; (ii) immunoﬂuorescent images of spheroids and
monolayer cells [red = phosphorylated runx2 (day 3)/osteopontin (day 14), green = mNPs, blue = nucleus]. 10× objective, scale bar = 50 μm.
MSC migration from the spheroids was noted in both ﬁbroblast and osteoblast activated models. Phospho runx2 staining was also picked up
at day 3 (Supplementary Figure 9). Arrowheads denote osteopontin staining in MSC spheroid at day 14. (B) MSC and osteoblastic
diﬀerentiation markers during control and activated osteoblast wound healing model [days 1 and 3; graph represents n = 3 (pooled from n =
6), mean ± SD; stats indicate one-way ANOVA signiﬁcance (*) of activated compared to corresponding control]. MSC spheroid RNA was
harvested and analyzed via ﬂuidigm on days 1 and 3 of coculture with both the control and activated osteoblast wound models. Note
maintenance of MSC markers under all conditions, but increased osteoblastic markers under activated cultures, in particular the high runx2
expression in the activated day 3 model.
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phenotype markers, phosphorylated runt-related transcription
factor 2 (p-runx2, a transcription factor involved in activation of
bone related genes), and osteopontin (a mature bone
extracellular matrix protein) were carried out, respectively, at
days 3 and 14, as we have previously shown these to be
expressed at these time points during MSC diﬀerentiation to
osteoblasts.19 As before, no MSC migration was noted when
spheroids were cocultured with control models (i.e., no
scratch), while migration was clearly observed toward the
wound activated models (i.e., scratched) (Figure 3A). With
regard to MSC diﬀerentiation, no osteoblast markers were
noted with spheroids coculture with ﬁbroblast monolayers.
However, there was evidence for early p-runx2 staining at day 3
(Supplementary Figure 12) and clear expression of the mature
bone marker, osteopontin, and staining at day 14 (Figure 3A).
To analyze this further, spheroids were extracted from the gels
(so as not to include monolayer information in the analysis),
and RNA was isolated at days 1 and 3 from both control and
activated osteoblast wound cocultures and analyzed via ﬂuidigm
quantitative PCR with respect to various stem cell and early
osteoblast markers, including runx2. Results demonstrated a
large increase in MSC runx2 expression at day 3 in the activated
osteoblast model, with no elevation in the control model
(Figure 3B; Supplementary Figure 13). Meanwhile, chondro-
cyte diﬀerentiation was assessed via collagen type II
immunostaining and parallel spheroid RNA isolation and
analysis via ﬂuidigm for early chondrocyte markers at day 3.
MSC migration was again evident when cocultured with
wounded cocultures (Figure 4A), and evidence for collagen
type II expression in spheroids was identiﬁed (Figure 4A
subset). Fluidigm data supported chondrocyte diﬀerentiation in
spheroids, with a trend toward early chondrocyte markers
(COL1A1, ACAN, COMP, and SOX9) at day 3 (Figure 4B).
IL-6 Identiﬁed as Key Paracrine Signal for MSC
Migration from the Spheroid Niche. Finally we identiﬁed
the MSC migratory signal released by the ﬁbroblasts,
osteoblasts, and chondrocytes during the wound healing
process. Following a literature search, an initial luminex
multiplex assay of ﬁve potential cytokine candidates was run
on media isolated from activated and nonactivated ﬁbroblast
and osteoblast monolayers (IL-1b, IL-2, IL-6, TNF-α, and IL-
12p70). The only cytokine increased in all cultures was IL-6
(Figure 5A). IL-6 was subsequently added to spheroid cultures
at physiological concentrations detected in the luninex assay
(450 pg/mL) to assess for MSC migration on demand; cells
were noted to begin migrating from the spheroid following 12 h
IL-6 treatment and were clearly visible by 24 and 48 h. MSCs in
control conditions (no IL-6 treatment) remained within their
spheroids (Figure 5B).
CONCLUSIONS
In conclusion, we have developed a MSC regeneration
responsive, functional tissue engineered MSC bone marrow
niche in vitro. The primary MSC spheroids clearly express
STRO-1 and nestin and remain quiescent up to day 14 in
culture. During culture they can be stimulated to transmigrate
from the “niche” in response to injury and diﬀerentiate on
engraftment, in particular to IL-6 migratory signals. Further
work will conﬁrm that diﬀerentiation is truly tissue speciﬁc and
not generic osteochondral diﬀerentiation. This in itself is a very
simple, eﬃcient, and cost-eﬀective model to produce and
maintain. The presence of the magnetic nanoparticles not only
facilitates rapid formation of spheroids in culture but also will
permit cell tracking and monitoring postspheroid formation via
either light microscopy or ﬂuorescent microscopy (due to a
conjugated ﬂuorescent tag), with the potential for magnetic
resonance imaging in vivo.
Such models will be invaluable for stem cell biology and in
new clinical developments. For example, this model will
facilitate the understanding of homing mechanisms and
subsequent engraftment of MSCs in the target-injured tissue.
This area of research is currently diﬃcult to study due to the
lack of robust, reproducible humanized in vitro model systems.
Speciﬁcally, while integrins are known to play a key role in
MSC motility (adhesion and migration), the participation of
additional factors involved in transmigration such as growth
factors, matrix metalloproteinases, and chemokines (e.g.,
CXCR4-SDF-1 axis) remains largely unknown. The unravelling
of the roles of these and other factors will be crucial in
enhancing MSC homing and engraftment in clinical use.
Furthermore, functional nanoniches cultured in tissue plastic
wells will permit drug screens to ﬁnd new leads to aid
regeneration. For example, testing of drugs to promote
osteogenesis to aid in therapy, such as for osteoporosis,
where reduction in bone density results in weakened bones.
Overall our in vitro tissue engineered MSC bone marrow
niche provides the potential to study MSC regeneration
response to both injury and disease conditions, thus facilitating
the study of natural repair mechanisms and the processes
involved in replacing diseased tissues.
Figure 4. MSC chondrogenic diﬀerentiation during wound healing.
(A) MSC migration and chondrocyte diﬀerentiation assessed at day
3 of culture, in control and activated ﬁbroblast and chondrocyte
wound models. (i) Light microscopy image of spheroids and
corresponding (ii) immunoﬂuorescent images of spheroids and
monolayer cells (red = collagen type II, green = mNPs, blue =
nucleus). 10× objective, scale bar = 50 μm. MSC migration from
the spheroids was noted in both activated models, while collagen II
was identiﬁed in chondrogenic activated models only. (B)
Chondrogenic diﬀerentiation markers during control and activated
chondrocyte wound healing model (days 3). MSC spheroid RNA
was harvested and analyzed via ﬂuidigm on days 3 of coculture with
both the control and activated chondrocyte wound models and
expressed as a heat map. Higher expression trends of chondrogenic
markers were identiﬁed in the activated day 3 model (collagen type
I alpha I, aggrecan, cartilage oligomeric matrix protein and sox9).
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METHODS/EXPERIMENTAL
Magnetic Nanoparticles. The mNPs employed were 200 nm in
diameter, with an iron oxide core (Fe3O4) coated in polydimethyl-
amine, with or without a FITC ﬂuorescent tag (green) (Chemicell,
Germany).
Cell Culture. The MSCs (Promocell, Germany) were cultured in
modiﬁed alpha-MEM media (10% FBS, 2% antibiotics) (Sigma-
Aldrich,U.K.) at 37 °C with 5% CO2. Once conﬂuent, the cells were
trypsinized, centrifuged, resuspended in fresh media, and seeded into
appropriate wells for experiments.
Monolayer Culture System. The MSCs were seeded into a 24-
well plate (3 × 104 cells/well) and incubated overnight in 1 mL of
media. Fresh media containing mNPs (0.1 mg/mL) was then added to
the cultures, and cells were incubated for a further 30 min in the
presence of a magnetic ﬁeld (Supplementary Figures 1−3). Cells were
washed, trypsinized, centrifuged resuspended in media, and seeded
onto sterile glass coverslips (13 mm diameter) for the appropriate
incubation period (Supplementary Figures 4 and 5). Media was
changed every 3 days.
Spheroid Culture System. The MSCs were seeded at a
concentration of 1 × 104 cells/well and, following incubation with
the mNPs, were trypsinized, pooled together, and centrifuged. The
cells were resuspended in fresh media (0.5 mL/sample), and 0.5 mL of
cell suspension was added to 4 mL fresh media/well (6-well plate). A
single neodymium magnet (15 × 5 mm, 3500 G/350 mT;
First4magnets, U.K.) was placed on top of the well, and the plate
was incubated for the required experimental period. Cells levitated into
spheroids within hours (Supplementary Figure 5). Media was changed
every 3 days.
Cell Viability. After the appropriate incubation period, the cells
were assessed for cell viability (LIVE/DEAD Viability/Cytotoxicity
Kit, Invitrogen) by preparing 1 mL of fresh media containing 1 μL
calcein AM and 1 μL ethidium homodimer (1 mL/sample). This
media was added to the cultures for 1 h at 37 °C. The cells were
washed three times with fresh media and analyzed immediately
afterward.
Immunostaining. STRO-1/Nestin/Phosphorylated runx2/Osteo-
pontin. Following mNP incubation, the cells were washed with PBS,
ﬁxed for 15 min with 4% paraformaldehyde/PBS, permeabilized for 5
min (10.3% sucrose, 0.3% NaCl, 0.06% MgCl2, 0.5% HEPES, and 0.5%
Triton X in PBS), and then 1% BSA/PBS was added to each well for 5
min. Subsequently, anti-STRO-1/antinestin/antiphosphorylated
runx2/antiosteopontin (1:50 in 1% BSA/PBS) was added for 1 h at
37 °C, washed well with 0.5% Tween 20/PBS, followed by incubation
with a relevant biotinylated secondary (1:50 in 1% BSA/PBS) for 1 h
at 37 °C. The cells were washed, and ﬁnally streptavidin-Texas Red
(1:50 in 1% BSA/PBS) was added to each well for 30 min at 4 °C.
Following washing, cells were mounted with DAPI.
BrdU. Cells were assessed for quiescence via BrdU incorporation
(Cell Proliferation Kit, GE Healthcare Life Sciences). Following mNP
incubation, 6 h prior to ﬁxing the cells, 1 mM BrdU solution in
DMEM was added to each sample. The cells were washed, ﬁxed, and
permeabilized using the same method as the STRO-1/Nestin
immunostaining protocol. Following permeabilization, 1% BSA/PBS
was added for 10 min. Subsequently, anti-BrdU (1:100 in DNase) was
added for 2.5 h, washed with 0.5% Tween 20/PBS, and a secondary
Texas Red (1:50 in 1% BSA/1× PBS) was added and incubated for 1
h. The cells were washed and ﬁnally mounted with DAPI.
Figure 5. MSC migratory signal identiﬁed as IL-6. (A) Luminex data plot of IL-6 response from ﬁbroblast, osteoblast, and chondrocyte control
(unscratched) and activated (scratched) monolayers over 24 h (graph represents n = 3, mean ± SD; stats indicate one-way ANOVA
signiﬁcance (*) for activated compared to corresponding control). (B) Corresponding MSC migration from spheroids in response to 450 pg/
mL IL-6 added to spheroid media.
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Actin. Following the addition of mNPs and after the appropriate
incubation period, the cells were washed, ﬁxed, and permeabilized
using the same method as the STRO-1/Nestin immunostaining
protocol. Following permeabilization, 1% BSA/PBS was added for 5
min. F-actin was stained using rhodamine-phalloidin (Invitrogen,
U.K.) (1:500 in 1% BSA/PBS) for 1 h. The cells were washed with
0.5% Tween 20/PBS and mounted onto slides with DAPI.
All ﬂuorescent images were taken using a Zeiss Axiovert 200 M
ﬂuorescent microscope.
Wound Healing Assay. Collagen Spheroid Preparation. All
reagents were maintained on ice prior to use. 0.5 mL fresh media with
0.5 mL 10× DMEM (First Link, U.K.) and 0.5 mL FBS were mixed
together. 2.5 mL acid solubilized collagen Type I solution (First Link,
U.K.) and 1 mL 0.1 M NaOH were prepared, mixed homogeneously,
and then added to the FBS mixture. A dropwise addition of 0.1 M
NaOH was then added to the mixture to neutralize the acid solution,
until pH 7 (pink color change). The suspension was then added to the
appropriate wells in a 24-well plate (0.5 mL), and preformed spheroids
were placed in the collagen gel, which was then incubated for the
required experimental period. Media was changed every 3 days.
Fibroblast and Primary Osteoblast Monolayer Wound Assay.
Brieﬂy, both h-TERT (telomerase altered human dermal ﬁbroblasts
(ATCC, U.K.)(1 × 105 cells/well) and primary osteoblasts (5 × 104
cells/well) (Promocell, Germany) were cultured as a conﬂuent
monolayer and left either unscratched or scratched with a P1000
pipet tip (Supplementary Figure 6). For the osteoblast monolayer
culture, cells were seeded onto CellBind plates (VWR Chemicals,
U.K.), and osteogenic induction media (DMEM, 10% FBS, 2%
antibiotics, 350 mM ascorbate-2-phosphate and 0.1 μM Dexametha-
sone) was added every 2/3 days for 10 days prior to the scratch, and
collagen spheroid was added immediately after the induced scratch and
monitored for the appropriate period.
RNA Extraction. RNeasy micro kit (Qiagen, U.K.) and RNase-free
water were used during this experimental setup. After the appropriate
incubation period, cells were lysed with 1 mL of TRIzol (Life
Technologies, U.K.) for 10 min and then centrifuged for 15 min. The
supernatant was transferred and mixed thoroughly with 200 μL
chloroform and left for 3 min. The mixture was centrifuged for 15 min,
the aqueous phase was removed, and glycoblue (1 μL) and
isopropanol (500 μL) were added to the solution. The Eppendorf
tubes were inverted several times and left for 10 min, followed by
centrifugation for 20 min. The supernatant was removed leaving a blue
pellet, which was vortexed with 1 mL ethanol (75% aq) and then
centrifuged for 5 min. The ethanol was removed to air-dry the pellet,
and water (20 μL) was added to the samples, which were incubated for
10 min. Each sample was made up to 350 μL with buﬀer RLT and
vortexed, followed by addition of 70% ethanol (350 μL). This was mix
thoroughly and transferred to a spin column for centrifuging for 15 s.
Buﬀer RW1 (350 μL) was added to the spin column and centrifuged
for 15 s, and 80 μL DNase I solution in buﬀer RDD (1:8 dilution) was
added to the column for 15 min. 350 μL buﬀer RW1 was added to the
column and centrifuged for 15 s. 500 μL buﬀer RPE was added to the
spin column and centrifuged for 15 s, and 500 μL of 80% ethanol was
added. The column was centrifuged at full speed for 2 min. The spin
column was further centrifuged at full speed for 5 min. The dried spin
column was placed in a 1.5 mL Eppendorf tube, and 14 μL water was
added then centrifuged at full speed for 1 min.
Analysis was conducted on conﬂuent primary osteoblast mono-
layers, which were either left unscratched or scratched with a P1000
pipet tip. Cells were seeded onto CellBind plates, and osteogenic
diﬀerentiation media was added for 10 days, prior to the addition of
collagen spheroid implant cultures. After 24 or 72 h, the collagen gels
containing the spheroids were removed from the wells ready for RNA
extraction. Six samples were pooled for each replicate (n = 3).
Fluidigm Analysis. The RNA was subjected to a reverse
transcription using the SuperScript III Reverse Transcriptase
(Invitrogen, U.K.). At all stages of the process, reactions were
preformed at 4 °C unless stated. Eleven μL of each sample was added
to 1 μL of oligo(dT) and 1 μL dNTPmix and then heated to 65 °C for
5 min. A mixture containing 4 μL 5× First Strand buﬀer, 1 μL 0.1 M
DTT, 1 μL RNaseOUT Recombinant RNase inhibitor, 0.5 μL
SuperScript III RT and 0.5 μL water was prepared and added to each
sample and left for 5 min. The solution was then incubated at 50 °C
for 30 min followed by 70 °C for 15 min providing cDNA. All 48
primers were pooled together (1 μL from each primer set pooled in
152 μL of DNA suspension buﬀer). A new solution was prepared with
1.25 μL of the cDNA of each sample, 2.5 μL 2× TaqMan PreAmp
Master Mix (Applied Biosystems), 0.5 μL pooled primer mix, and 0.75
μL water. This was vortexed, centrifuged, and subjected to 22 thermal
cycles with the following program (Table 1):
After the 22 thermal cycles, 1.4 μL water, 0.2 μL Exonuclease I
Reaction Buﬀer, and 0.4 μL Exonuclease were added to each sample
and vortexed, centrifuged, and incubated at 37 °C for 30 min and then
80 °C for 15 min. After heating, 18 μL of TE buﬀer was added to each
sample. 2.7 μL of the exonuclease I treated sample was added to 3.0
μL 2× SsoFast EvaGreen Supermix (Bio-Rad) and 0.3 μL 20× DNA
Binding Dye sample loading reagent (Fluidigm). Each mixture was
vortexed and centrifuged ready to be loaded onto the chip.
Additionally, 0.3 μL of each individual primer set was added to 3
μL 2× assay loading reagent and 2.7 μL 1× DNA suspension buﬀer
that was vortexed and centrifuged, ready for loading on the chip and
run on the Fluidigm Biomark HD system. A 48.48 Dynamic array IFC
was used during this analysis.
Luminex 100 Analysis. As a conﬂuent monolayer, either primary
osteoblasts or h-TERTs were used and left either unscratched or
scratched using a P1000 pipet tip. For the osteoblast monolayer
culture, cells were seeded as a conﬂuent monolayer onto CellBind
plates, and osteogenic diﬀerentiation media was added every 2/3 days
for 10 days and then either scratched or left unscratched. While for the
h-TERTs monolayer, cells were seeded as a conﬂuent monolayer and
left for 24 h, then either scratched or left unscratched.
Fresh media was added, and the supernatant was removed after 3,
12, 24, and 72 h, and the Bio-Rad Bio-Plex Pro cytokine assay protocol
was used to analyze the cytokines. All solutions used were prepared
from the Bio-Rad Pro Human Cytokine Group I, 5-plex assay kit
except for the fresh media. Each supernatant was centrifuged at 1000 g
at 4 °C for 15 min, and the media was removed, ready for processing.
The standard was reconstituted with fresh media, and 8 serial dilutions
(1:4) were followed with fresh media to create a standard curve as
described in the protocol. A control blank was prepared with fresh
media. Each sample was additionally diluted (1:4) with fresh media.
Stock solutions (10×) of conjugated coupled magnetic beads were
pooled together with assay buﬀer to make a single 1× solution. The
plate was prewetted with 100 μL assay buﬀer, which was removed, and
50 μL of the 1× magnetic beads solution was added. Prior to the
removal of each solution from the plate, a magnetic plate was applied
to retain the beads within the wells. The solution was removed, and
the plate was washed twice with 100 μL of wash buﬀer. The standards,
samples, and blanks (50 μL) were added to the appropriate wells and
left covered, shaking at room temperature for 30 min. After the
appropriate incubation period, the solution was removed and the wells
were washed thrice with wash buﬀer (100 μL). Stock solutions (10×)
of detection antibodies were mixed together and diluted to create a 1×
solution with detection antibody diluent. The 1× solution was added
to the wells (25 μL) and left covered, shaking at room temperature for
30 min. After the appropriate incubation period, the solution was
removed, and the wells were washed thrice with wash buﬀer (100 μL).
Stock solution (100×) of streptavidin-PE was diluted to create a 1×
solution with assay buﬀer. The 1× solution was added to the wells (50
μL) and left covered, shaking at room temperature for 10 min. After
the appropriate incubation period, the solution was removed, and the
Table 1
condition hold 22 cycles hold
temperature 95 °C 95 °C 60 °C 4 °C
time 10 min 15 s 4 min ∞
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wells were washed thrice with wash buﬀer (100 μL). The beads were
resuspended with assay buﬀer (125 μL) ready for analysis.
Primer Sequences (Fluidigm). Primer sequences can be found in
Table 2.
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